BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12736720)

  • 21. [Growth inhibition of human pancreatic cancer by farnesyl transferase inhibitor].
    Kainuma O; Asano T; Hasegawa M; Isono K
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1657-9. PubMed ID: 8886038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
    Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
    Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice.
    Saha B; Nandi D
    Hepatology; 2009 Nov; 50(5):1547-57. PubMed ID: 19739265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes.
    Scheving LA; Buchanan R; Krause MA; Zhang X; Stevenson MC; Russell WE
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G552-9. PubMed ID: 17585012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular simian virus 40 induces an ERK/MAP kinase-independent signalling pathway that activates primary response genes and promotes virus entry.
    Dangoria NS; Breau WC; Anderson HA; Cishek DM; Norkin LC
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2173-82. PubMed ID: 8811017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
    Whitehurst CE; Geppert TD
    J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-mediated cell proliferation and survival involve inhibition of c-Jun N-terminal kinases through a phosphatidylinositol 3-kinase- and mitogen-activated protein kinase phosphatase-1-dependent pathway.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Caron M; Atfi A; Cherqui G; Capeau J
    Endocrinology; 2000 Mar; 141(3):922-31. PubMed ID: 10698166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cdc42-dependent mediation of UV-induced p38 activation by G protein betagamma subunits.
    Seo M; Cho CH; Lee YI; Shin EY; Park D; Bae CD; Lee JW; Lee ES; Juhnn YS
    J Biol Chem; 2004 Apr; 279(17):17366-75. PubMed ID: 14970210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization.
    Sonoda K; Sakamoto T; Yoshikawa H; Ashizuka S; Ohshima Y; Kishihara K; Nomoto K; Ishibashi T; Inomata H
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2245-51. PubMed ID: 9804132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cell growth of human hepatoma cell line (Hep G2) by a farnesyl protein transferase inhibitor: a preferential suppression of ras farnesylation.
    Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Matsuzawa Y
    Int J Cancer; 1996 Mar; 65(5):620-6. PubMed ID: 8598313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptidoglycan induces nuclear factor-kappaB activation and cyclooxygenase-2 expression via Ras, Raf-1, and ERK in RAW 264.7 macrophages.
    Chen BC; Chang YS; Kang JC; Hsu MJ; Sheu JR; Chen TL; Teng CM; Lin CH
    J Biol Chem; 2004 May; 279(20):20889-97. PubMed ID: 15007072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenocorticotropin induces mitogen-activated protein kinase phosphatase 1 in Y1 mouse adrenocortical tumor cells.
    Bey P; Gorostizaga AB; Maloberti PM; Lozano RC; Poderoso C; Cornejo Maciel F; Podestá EJ; Paz C
    Endocrinology; 2003 Apr; 144(4):1399-406. PubMed ID: 12639923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice.
    Sugita M; Sugita H; Kaneki M
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1390-5. PubMed ID: 17363690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
    Feldkamp MM; Lau N; Guha A
    Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
    Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
    Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway.
    Suhasini M; Li H; Lohmann SM; Boss GR; Pilz RB
    Mol Cell Biol; 1998 Dec; 18(12):6983-94. PubMed ID: 9819386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
    J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.